Project description
Recreating a patient's tumour ecoystem with 3D printing will foster precision treatment
One of the key problems with experimentation in model systems is the adequacy of the model system in representing the human disease or condition to be evaluated. In the case of cancer, it has become clear that the interaction of tumour cells with their microenvironment is critical to disease progression, metastasis and response to therapy. 3DCanPredict is developing a novel analytical system utilising a 3D bioprinted tumour model exploiting hydrogel scaffolds and a patient's own tumour cells. With functional blood vessels that can be infused with the patient's serum via a pump, not only does the system mimic the tumour microenvironment but it opens the door to personalised cancer medicine.
Fields of science
Programme(s)
Funding Scheme
ERC-POC-LS - ERC Proof of Concept Lump Sum PilotHost institution
69978 Tel Aviv
Israel
See on map
Beneficiaries (1)
69978 Tel Aviv
See on map